<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CUE5XGT9</identifier><date>2014</date><creator>Anderluh, Marko</creator><creator>Knez, Damijan</creator><relation>documents/doc/C/URN_NBN_SI_doc-CUE5XGT9_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CUE5XGT9_001.txt</relation><format format_type="issue">3</format><format format_type="volume">65</format><format format_type="type">article</format><format format_type="extent">str. 227-233</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">3692657</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CUE5XGT9</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">blood-brain barrier</subject><subject language_type_id="slv">farmakološki učinki</subject><subject language_type_id="slv">in silico modeli</subject><subject language_type_id="eng">in silico models</subject><subject language_type_id="slv">krvno-možganska pregrada</subject><subject language_type_id="slv">napovedovanje prehajanja</subject><subject language_type_id="eng">prediction of permeability</subject><subject language_type_id="slv">prenašalci spojin</subject><title>Blood-brain barrier permeation in development of central nervous system agents</title><title>Prepustnost krvno-možganske pregrade pri razvoju učinkovin z delovanjem v osrednjem živčevju</title></Record>